BroadOak Capital Partners
Status
ACTIVE
Global HQ
Maryland, United States
Countries of investment
- USA
- Asia
Investment stages
- Seed
Industries
- Biotechnology
- Health Tech
- AI
- Data Science
About
BroadOak Capital Partners is a boutique financial institution that specializes in providing direct investment and banking services specifically tailored for life sciences and biopharma services companies.
BroadOak Capital Partners is a boutique financial institution that specializes in providing direct investment and banking services specifically tailored for life sciences and biopharma services companies.
Investment Thesis
BroadOak Capital Partners focuses on providing growth capital and advisory services to life sciences companies that are underserved or overlooked by traditional financial services providers. They invest in companies operating in the life sciences tools, diagnostics, and biopharma services sectors, with an emphasis on cell and gene therapy and related sectors.
Manager's Experience
Possessing extensive experience in investment management, the fund manager has successfully navigated multiple sectors, including technology and healthcare. With a strong emphasis on data-driven strategies, they have overseen over 30 deals across North America and Europe, showcasing a keen ability to identify growth opportunities. Their operator-first approach has led to several notable exits, further underscoring their proficiency in venture capital and late-stage investment. A thematic focus on innovation has positioned them as a strategic leader in the competitive landscape.
Team
Tim Johnson
Michael Caspani
Lars Hanan
Kyle Wilson
Daniel Friedman
Bryan Poltilove
Bill Snider
Aaron Fisher
Matthew M